MHRA receives 75% of its funding from device manufacturers / pharmaceutical companies

By /

Esther McVay addresses parliament on the concerns surrounding the MHRA and their funding model

Related Posts

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top